Related Experiment Video
Updated: Jan 29, 2026

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
MicroRNA-based Targeted Therapeutics in Pancreatic Cancer
Nilgun Gurbuz1, Bulent Ozpolat2
1Department of Medical Biology, School of Medicine, Suleyman Demirel University, Isparta, Turkey.
Abstract:
The discovery during the last decade of microRNAs (miRs, miRNA) and their role in regulating normal physiological processes as well as in the pathogenesis of human tumors has been a revolutionary development in molecular oncology. miRNAs activating or inhibiting oncogenic molecular pathways that are involved in tumorigenesis, cell progression, invasion, angiogenesis and metastasis are now considered of major impact in many cancer types. miRNA-based therapeutics that inhibit the levels of oncogenic miRNAs (oncomiRs) or elevate tumor suppressor miRs have enormous potential as molecular therapeutic targets. Thus, the development of new targeted cancer therapies based on miRNAs promise to revolutionize cancer treatment due to their increased efficacy compared to conventional chemoradiation-based therapies and hopefully to lower levels of adverse effects.
Insights
MicroRNAs (miRNAs) are revolutionizing molecular oncology by regulating cancer pathways. miRNA-based therapies offer promising, targeted cancer treatments with potentially fewer side effects than traditional methods.
Area of Science:
- Molecular Oncology
- Genetics
- Biotechnology
Background:
- MicroRNAs (miRNAs) have emerged as critical regulators in both normal physiology and human tumor pathogenesis over the past decade.
- These small non-coding RNAs significantly impact tumorigenesis, cell progression, invasion, angiogenesis, and metastasis by modulating oncogenic pathways.
- Their dysregulation is implicated in numerous cancer types, highlighting their role in disease development.
Purpose of the Study:
- To explore the revolutionary impact of microRNAs in molecular oncology.
- To discuss the potential of miRNA-based therapeutics in cancer treatment.
- To highlight the promise of targeted miRNA therapies over conventional treatments.
Main Methods:
- Review of recent discoveries and research in microRNA biology and cancer.
- Analysis of the role of miRNAs in oncogenic pathways and cancer progression.
- Evaluation of the therapeutic potential of inhibiting oncogenic miRNAs (oncomiRs) or restoring tumor suppressor miRNAs.
Main Results:
- MicroRNAs are key regulators of critical molecular pathways in cancer.
- Oncogenic miRNAs (oncomiRs) and tumor suppressor miRNAs are significant players in tumorigenesis.
- miRNA-based therapeutics demonstrate potential for targeted cancer treatment.
Conclusions:
- MicroRNAs represent a revolutionary advancement in molecular oncology.
- miRNA-based therapeutics hold significant promise for developing more effective and potentially safer cancer treatments.
- Targeted miRNA therapies could transform cancer care, offering improved efficacy and reduced adverse effects compared to chemoradiation.
More Related Videos
Related Concept Videos
MicroRNAs
MicroRNAs
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cardiovascular Drugs: Classification based on Therapeutic Indications
Therapeutic Index
Therapeutic Communication
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...

